Authors
Loading...
Recombinant ASFV-ΔE120R demonstrates full attenuation and induces humoral and cellular immunity, suggesting vaccine potential.
Ma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: